Eton Pharmaceuticals (ETON) Cash from Investing Activities (2020 - 2025)

Eton Pharmaceuticals has disclosed Cash from Investing Activities across 6 years of filings, most recently posting -$49000.0 for Q4 2025.

• In Q4 2025, Cash from Investing Activities rose 99.87% year-over-year to -$49000.0; the TTM figure through Dec 2025 stood at -$333000.0 (up 99.17% YoY), while the FY2025 annual figure was -$333000.0, up 99.17% from the prior year.
• Cash from Investing Activities came in at -$49000.0 for Q4 2025 at Eton Pharmaceuticals, up from -$284000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$2000.0 in Q3 2021 to a low of -$38.1 million in Q4 2024.
• Average Cash from Investing Activities over 5 years is -$4.3 million, with a median of -$761000.0 recorded in 2022.
• Year-over-year, Cash from Investing Activities tumbled 99900.0% in 2022 and surged 99.87% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$3.3 million in 2021, then surged by 99.63% to -$12000.0 in 2022, then slumped by 6358.33% to -$775000.0 in 2023, then plunged by 4820.26% to -$38.1 million in 2024, then soared by 99.87% to -$49000.0 in 2025.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$49000.0 in Q4 2025, -$284000.0 in Q3 2025, and -$38.1 million in Q4 2024.